ADHERENCE TO TREATMENT AND RISK FACTOR CONTROL IN PATIENTS AFTER CORONARY STENTING DEPENDING ON REGULAR OR REMOTE FOLLOW-UP

Background and Aims: The remote monitoring after coronary stenting (CS) may facilitate adherence to treatment and risk factor control. Aim: to evaluate the adherence to drug therapy and risk factor control in patients after CS receiving remote monitoring or care with outpatient visits. Methods: 279 consecutive stable CAD patients after CS were randomized into groups of regular outpatient visits (group 1, n=96, cardio exam and blood testing), remote monitoring (group 2, n=95, videoconference, telephone care and blood tests interpretation) and control group (group 3, n=88, cared by a physician at the residence place). Adherence to medical therapy using four-item Morisky Green Levine Medication Adherence Scale was assessed at baseline, 1, 3, 6 and 12 mo after CS in groups 1 and 2 and at baseline and 12 mo in group 3. Results: An increase in the number of highly adherent individuals vs. baseline (33 vs. 17 and 42 vs. 13, respectively, p <0.05), was observed in groups 1 and 2. The non-adherence to DAAT was 1-2%, while 32,3%, 29,5%, 57.9% of patients in groups 1, 2, 3 reduced/ceased statins 12 mo after CS (p<0.05 group 3 vs. 1 and 2). BP level decrease was observed in groups 1 and 2, the number of smokers decreased in group 2 (46.3 to 31.6%, p <0.05). Conclusions: The remote monitoring is a safe and effective strategy for improving adherence to treatment and risk factor control in patients after CS.